Breaking News, Financial News

Abbott Laboratories 3Q

Abbott Laboratories

3Q Revenues: $6.4 billion (+14%)

3Q Earnings: $717 million (flat)

YTD Revenues: $18.7 billion (+15%)

YTD Earnings: $2.4 billion (+10%)

Comments: Pharma sales grew 20% to $3.5 billion in 3Q07, driven by growth in Humira, Kaletra and TriCor sales. Earnings were impaired by costs related to a buyout of Guidant’s stent business.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters